Press Releases European Medical Solutions

Equities

DMSIM

BE0974289218

Real-time Euronext Bruxelles Other stock markets 08:46:38 2024-06-28 am EDT			5-day change	1st Jan Change
0.0198 ^EUR	0.00%		-13.16%	-15.74%

Apr. 21	DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DMS Imaging : Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024	Apr. 18	PU
Dms Imaging : DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.	23-05-23	AT
Dms Imaging : Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives	23-04-20	AT
Dms Imaging : 2022 revenue: EUR 35.3 m - 2023 targets and perspectives	23-01-20	AT
Dms Imaging : Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging	23-01-12	AT
Dms Imaging : 2022 bi-annual results	22-10-03	AT
DMS Imaging : Annual Financial Report 2021	22-08-01	PU
DMS Imaging: Publication Regarding a Transparency Notification	22-02-28	BU
ASIT biotech : 2020 annual financial report	21-04-30	PU
Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight \| Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.	21-04-16	AQ
ASIT biotech : presents its 2020 half year results and provides a business update until end 2020	20-09-30	PU
ASIT biotech : 2020 interim financial report as of June 30, 2020	20-09-30	PU
ASIT biotech : Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020	20-09-30	BU
ASIT biotech : Annexe 1bis - cash position (french only)	20-09-20	PU
ASIT biotech : Obtains the Benefit of the Judicial Reorganization by Collective Agreement	20-02-12	BU
ASIT biotech : Reintroduces an Application for Judicial Reorganization and Modifies the Composition of Its Board of Directors	20-01-20	BU
ASIT biotech : Discloses Next Steps Following gp-ASIT+TM Phase III Results	19-12-20	BU
ASIT biotech : mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)	19-10-17	PU
ASIT biotech Mode of Action Study of gp-ASIT+™ for Grass Pollen Allergy Published in The Journal of Allergy and Clinical Immunology (JACI)¹	19-10-17	GL
ASIT biotech Receives GMP Certification for its Manufacturing Site in Liège, Belgium	19-10-07	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases European Medical Solutions

Equities

DMSIM

BE0974289218

Press Releases

Filters